Literature DB >> 29352650

Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan.

Tsuyoshi Kitaura1, Masamichi Takahashi2, Takashi Umeyama3, Nozomi Takeshita4, Yuichi Katanami1, Saho Takaya1, Kei Yamamoto1, Satoshi Kutsuna1, Kayoko Hayakawa1, Yasuyuki Kato1, Takahiro Yamauchi2, Yoshitaka Narita2, Yoshitsugu Miyazaki3, Norio Ohmagari1.   

Abstract

A 71-year-old Japanese man with travel history to the Vancouver Island, Canada was diagnosed the pulmonary and central nervous system infections caused by Cryptococcus gattii genotype VGIIa. This is the first imported case of Cryptococcus gattii genotype VGIIa infection from endemic area of North America to Japan. He was recovery with no residual neurological dysfunction by early resection of brain mass and antifungal therapy. Early surgical resection of cerebellar cryptococcoma may shorten the length of induction therapy with antifungal drugs.
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cryptococcosis; Cryptococcus gattii; Japan; Surgery; Travel; Vancouver Island

Mesh：

Substances：

Year:  2018        PMID： 29352650     DOI： 10.1016/j.jiac.2017.12.014

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN： 1341-321X            Impact factor:   2.211


  3 in total

1.  Phenotypic characteristics and transcriptome profile of Cryptococcus gattii biofilm.

Authors:  Eliandro Reis Tavares; Bárbara Gionco; Ana Elisa Belotto Morguette; Gabriella Maria Andriani; Alexandre Tadachi Morey; Anderson Oliveira do Carmo; Ulisses de Pádua Pereira; Galdino Andrade; Admilton Gonçalves de Oliveira; Phileno Pinge-Filho; Celso Vataru Nakamura; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

2.  Cryptococcus deuterogattii VGIIa Infection Associated with Travel to the Pacific Northwest Outbreak Region in an Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibody-Positive Patient in the United States.

Authors:  Shelly Applen Clancey; Emily J Ciccone; Marco A Coelho; Joie Davis; Li Ding; Renee Betancourt; Samuel Glaubiger; Yueh Lee; Steven M Holland; Peter Gilligan; Julia Sung; Joseph Heitman
Journal:  mBio       Date:  2019-02-12       Impact factor: 7.867

3.  Treatment of Cryptococcus gattii Infection Using Voriconazole.

Authors:  Makoto Nakao; Kohei Fujita; Sousuke Arakawa; Shuntaro Hayashi; Saori Tomita; Hidefumi Sato; Hideki Muramatsu
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.